Precursor Condition
Squamous Cell Intraepithelial Neoplasia
CI-CAN-00001551SIL · SINExplore in graph →
Precursor19 active trials
- NCIt
- C8334
Loading cancer entity…
Loading cancer entity…
Precursor Condition
CI-CAN-00001551SIL · SINExplore in graph →
Clinical trials
115 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05916911 | Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR) | unknown | Phase 4 | 120 | Catalysis SLINDUSTRY | 1 |
| Feb 7, 2024 |
| clinicaltrials |
| NCT06208319 | Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance(IACOL) | unknown | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Feb 1, 2024 | clinicaltrials |
| NCT02937155 | In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? | unknown | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT05051852 | HPV Viral Load in Predicting the Prognosis of LSIL | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05282745 | A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL | unknown | — | 4,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05283239 | Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05858021 | COrSIcA: Disease Measurement | unknown | — | 30 | David FinchOTHER | 0 | May 15, 2023 | clinicaltrials |
| NCT05835947 | Anal Cancer Risk In Women | unknown | — | 200 | Imperial College LondonOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05835960 | Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma | unknown | — | 20 | Imperial College LondonOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05808816 | "Lactobacillus Crispatus M247, LSIL and Microbiota" | unknown | Phase 4 | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05745597 | Prognostic Study of HPV Virus Integration in Women With HSIL | unknown | — | 1,000 | Fujian Maternity and Child Health HospitalOTHER | 1 | Feb 27, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05536843 | Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests(TTMV HPV DNA) | unknown | — | 500 | University of Mississippi Medical CenterOTHER | 0 | Sep 13, 2022 | clinicaltrials |
| NCT03947775 | HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | unknown | Phase 2 | 228 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03113942 | Study of Pomalidomide in Anal Cancer Precursors(SPACE) | unknown | Phase 2 | 26 | Kirby InstituteOTHER_GOV | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05210348 | Clinical Evaluation of Detection of High Risk HPV in Urine(Urine-hrHPV) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT04109573 | Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)(FLAN) | unknown | N/A | 20 | Homerton University Hospital NHS Foundation TrustOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT03409471 | HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study | unknown | — | 300 | Korea University Guro HospitalOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03357991 | E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM(ELAVI-67) | unknown | — | 355 | Hospital Universitari de BellvitgeOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT03302858 | A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand | unknown | Phase 2 | 70 | Stephen E. GoldstoneOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT00365729 | Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men | unknown | — | 1,000 | Deutsche Luft und RaumfahrtOTHER_GOV | 1 | Jan 21, 2016 | clinicaltrials |
| NCT01909518 | Detection of Early Esophageal Squamous Neoplasia | unknown | — | 200 | Shandong UniversityOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00343213 | Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix. | unknown | N/A | 300 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 30, 2011 | clinicaltrials |
| NCT01416922 | oncoFISH Cervical Test for Detection of 3q26 Region Gain | unknown | — | 1,100 | Ikonisys, Inc.INDUSTRY | 1 | Aug 15, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Apr 17, 2024source: clinicaltrials